Industry Updates for the Psychedelics World

Psychedelics News

Industry

18 Jan 2022

Update on Revive Therapeutics Psilocybin Programs

Revive Therapeutics has just released an update of its psychedelic pipeline, so we thought it’d be a good time to check in and see what’s up....

By Jason Najum

Industry

13 Jan 2022

PharmaTher Receives FDA Approval for Ketamine Phase 2 Trial

PharmaTher has taken another important step in its clinical trial process....

By Microdose

Industry

12 Jan 2022

Field Trip’s FT-104 Clears Patent Approval Process

The Allowance is final major step in the patent process, with actual granting of the patent normally coming soon after....

By Jason Najum

Don’t Miss, Industry

11 Jan 2022

News You Might Have Missed: Jan 11th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

6 Jan 2022

Field Trip to Apply on Behalf of Patients for Psychedelic Access Program

Following up on yesterday's news that the Canadian government has officially amended regulations on its Special Access Program, Field Trip has announced that will help patients navigate these bureaucratic waters....

By Microdose

Industry

4 Jan 2022

MindMed Successfully Completes Phase 1 Trial of 18-MC

18-MC is MindMed's non-hallucinogenic proprietary derivative of ibogaine, being developed for the treatment of indications linked to opioid use disorder....

By Jason Najum

Industry

3 Jan 2022

Heath Canada Amends Special Access Program

The SAP is a process by which healthcare practitioners can petition the government for special access to restricted drugs on behalf of their patients....

By Microdose

Industry

29 Dec 2021

Psychedelics Year in Review: 2021

2021 was a seminal year for the space....

By Jason Najum

Industry

27 Dec 2021

PharmaTher Provides Update on Pipeline and Milestones for 2022

PharmaTher is one of the psychedelic medicine industry’s best kept secrets....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result